Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Senior Drug Safety Specialist

Biomedical Sciences · India · 2023-03-31

Processing Time
180 days
Decision Date
2023-03-31
Location
Virginia
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to focus on pre-clinical toxicity studies of novel small molecules and the safety monitoring of pharmaceutical therapies for conditions including alcohol and opioid dependence, schizophrenia, bipolar disorder, cancers, and neurodegenerative disorders. This work aims to develop viable new drug treatments and reduce preclinical trial costs.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor serves the healthcare interests of the U.S. by developing drug treatments for cancer and neurodegenerative disorders.

2 Well-positioned to Advance Endeavor Met

The petitioner is well-positioned due to her publication record, citation count, and role as a peer review moderator.

3 Waiver of Job Offer/Labor Certification Met

On balance, her work in reducing preclinical trial costs and advancing drug safety justifies a waiver of the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's M.Pharm. degree, 17 peer-reviewed scientific articles, and 231 citations from experts in 38 countries. Additionally, she conducted 25 peer reviews and demonstrated significant governmental funding and original contributions of major significance to the field.

Request for Evidence (RFE)

Successfully Addressed

USCIS issued an RFE questioning the strength of the case; the legal team responded with detailed evidence reinforcing the original arguments and highlighting the significance of the petitioner's contributions.

RFE Targets
Substantial Merit and National ImportanceWell-positioned to Advance EndeavorWaiver of Job Offer/Labor Certification

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Research and Development · South Korea

WeGreened EB-2 (NIW) approved
California 174 days 2022-09-29
The petitioner proposes to continue identifying lead molecules to develop novel drugs for treating cancer, autoimmune diseases, addiction, neurodegenerative diseases, and viral infections. The work specifically focuses on translesion synthesis to support the development of targeted therapeutics that circumvent drug resistance in cancer patients.
View Case

Postdoctoral Researcher

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
Maryland 350 days 2025-06-13
The petitioner proposes to continue her research in pharmacology, specifically focusing on assessing the pharmacokinetic properties of novel medications using in vitro and in vivo models to minimize adverse drug effects and maximize efficacy for conditions such as diabetes, Alzheimer’s, and cancer.
View Case

Scientist

Pharmaceuticals · Bangladesh

WeGreened EB-2 (NIW) approved
Massachusetts 69 days 2022-04-19
The petitioner proposes to continue analyzing synthetic routes to isolate, synthesize, design, and ensure the safety of novel drug molecules. This work is part of innovative drug discovery projects aimed at treating cancer, heart disease, and infectious diseases to improve global and U.S. healthcare outcomes.
View Case

Research Scientist

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Texas 296 days 2026-01-14
The petitioner proposes to advance pharmacological research by improving drug-conjugate therapies to create more selective delivery vehicles for cancer treatment. This work focuses on engineering therapeutic payloads to concentrate in tumor cells while limiting exposure to healthy tissue, thereby reducing off-target effects and collateral damage.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-03-31.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 180 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist